10times
7th Edition Trade Show

BioProcess International Conference & Exhibition China

12 - 13 Aug 2015  New Date Reminder
Grand Hyatt Shanghai, Shanghai, China
About Followers 26 Reviews Exhibitors Photos Speakers Travel Deals

"To bring China and the rest of the world together to explore the missing gaps in China's development."
BioProcess International Conference & Exhibition China is a much awaited medical show which will bring forth true advancement of Cell Line Engineering, Cell Culture, Media Development and at the same time concentrates on Characterization and Comparability for Biologics and Biosimilars. This is a two day medical show which will be taking place at Grand Hyatt Shanghai situated in the city of Shanghai. BioProcess International Conference & Exhibition China highlights the techniques and methods of bioprocesses and focuses on developing the research and scientific departments involved in cell line engineering. The exhibitors provide ample information on novel biologics and vaccine as well as different aspects of clinical trials will also be discussed by the experts who have years of experience in this industry.


Timings

07:30 AM - 05:45 PM (Aug 12) (General)
07:45 AM - 05:00 PM (Aug 13) (General)

Entry Fees

Check Official Website

Participants

5000 - 20,000
Visitors

100 - 500 Exhibitors Based on previous editions

Category & Type

Trade Show
IT & Technology

Editions

12 - 13 Aug 2015 7th Edition
19 - 20 Aug 2014 6th Edition
20 - 21 Aug 2013 5th Edition
21 - 22 Aug 2012
View More

Frequency Annual

Official Links

WebsiteContacts


Report Error
Claim this event
Event Happened Alongside

Organizer

Logo Follow Company

Informa Connect Top Rated

UK 717 Total Events / 86 Upcoming Events 253+ Followers

User Community [ Users who have shown interest for this Event ]

TABALA YOLANDE

TABALA YOLANDE

Expert

Kinshasa, Democractic Republic Of Congo
zahid umer

zahid umer

Ceo at Ever Bright Trader

Karachi, Pakistan
Muhammad Arif Sadiq

Muhammad Arif Sadiq

Lahore, Pakistan
Ibrahim Mohammed

Ibrahim Mohammed

Sales Manager at Adr

Dhaka, Bangladesh
Younes Maqbul Ahmed

Younes Maqbul Ahmed

Jeddah, Saudi Arabia
Eric Hyung-hoon Kim

Eric Hyung-hoon Kim

International Sales Director at UnK Trading

Seoul, South Korea
Victoria Vasilyeva

Victoria Vasilyeva

Ms. at Yuzhpharm

Krasnodar, Russia

Write a Review

Add Your Review

Schedule & Agenda

Wed, 12 Aug 07:30 AM - 08:20 AM
Registration and Coffee with Exhibit and Poster Viewing
Wed, 12 Aug 08:20 AM - 08:30 AM
Chairman's Remarks
Chengbin Wu, Ph.D., Chief Scientific Officer, President of R&D, Shanghai CP Guojian Pharmaceutical Co. Ltd., China
Wed, 12 Aug 08:30 AM - 09:00 AM
Robert Friesen, Ph.D. Exceptional Activities from Multi-specific Biologics using Novel Architectures
Therapeutic Biologics designed to bind to multiple targets drastically alter the landscape of drug development by achieving previously unattai ...continue reading
Wed, 12 Aug 09:00 AM - 09:30 AM
Rene Hoet, Ph.D. Innovative Strategies for Antibody Lead Discovery and Optimization at Bayer
This presentation will discuss some of the innovative strategies we are using for antibody lead discovery using in vitro display technologies, ...continue reading
Wed, 12 Aug 09:30 AM - 10:10 AM
Networking Refreshment Break with Exhibit and Poster Viewing
Wed, 12 Aug 10:10 AM - 10:15 AM
Chairman's Remarks
H. Fai Poon, Ph.D., Director, Cell Culture, Hisun Pharmaceutical (Hangzhou) Co., Ltd., China
Wed, 12 Aug 10:10 AM - 10:15 AM
Chairman's Remarks
Junyan Ji, Ph.D., Senior Scientist, Late Stage Pharmaceutical R&D, Genentech, a member of the Roche Group, USA
Wed, 12 Aug 10:15 AM - 10:45 AM
CHO Glycosylation Mutants for Production of Fucose-free and Galactose-free Antibody Therapeutics
Removal of core fucose from IgG1 antibodies is able to increase its affinity for FcgRIII and enhance ADCC. The galactose content of the N-glyc ...continue reading
Wed, 12 Aug 10:15 AM - 10:45 AM
Assay Improvement for Protein Therapeutics at Clinical Development Stage
Assay improvement (or change) is common in the CMC development of biological products, as developers gain a more comprehensive understanding o ...continue reading
Wed, 12 Aug 10:45 AM - 11:15 AM
Post-translation Modifications of Protein in Cell Culture
This presentation will discuss the mechanics of cell culture process development. It will also provide perspectives on evaluating post-transla ...continue reading
Wed, 12 Aug 10:45 AM - 11:15 AM
Challenges in ADC Formulation Development from Early Stage to Commercialization
Junyan Ji, Ph.D., Senior Scientist, Late Stage Pharmaceutical R&D, Genentech, a member of the Roche Group, USA
Wed, 12 Aug 11:15 AM - 11:45 AM
Development of qPCR Assay for Mycoplasma Detection in Biopharmaceutical GMP QC
Mycoplasma detection is one of the most time consuming assays in biopharmaceutical GMP QC. It takes twenty eight days with four subcultures; i ...continue reading
Wed, 12 Aug 11:45 AM - 12:15 PM
fortebio New Tools and Methods for Rapid, Label-Free Characterization in Biotherapeutic Drug Development
Bio-Layer Interferometry (BLI) from Pall ForteBio has gained a significant reputation as one of the leading technologies of label-free analysi ...continue reading
Wed, 12 Aug 12:15 PM - 01:30 PM
Networking Luncheon with Exhibit and Poster Viewing
Wed, 12 Aug 01:30 PM - 02:00 PM
Quality Issues: Inspection Readiness, Documentation, and Training for GMP, Quality Assurance and Operations
In this presentation we review current quality issues experienced by companies in China, focusing on actual examples from FDA records. We expl ...continue reading
Wed, 12 Aug 02:00 PM - 02:30 PM
Development of a Scale-Up Cell Culture Model Using Multivariate Analysis
Since there are geometric differences between scales, bioreactors at manufacturing scale often vary from bench scale performance. Such differe ...continue reading
Wed, 12 Aug 02:30 PM - 03:00 PM
Cell Culture and Upstream Processing
Abstract not available at time of print.Changlin Dou, Ph.D., Deputy General Manager, BoAn Biotechnology Company, A Subsidiary of Luye Pharma G ...continue reading
Wed, 12 Aug 03:00 PM - 03:30 PM
Kerry Inc Solutions for Improving Product Titer and Viral Yields in Biopharmaceutical and Vaccine Production
For over 30 years Kerry has provided novel supplements to help cell culture scientists increase product titer, virus yield and reduce/remove a ...continue reading
Wed, 12 Aug 03:30 PM - 04:15 PM
Networking Refreshment Break with Exhibit and Poster Viewing
Wed, 12 Aug 04:15 PM - 04:45 PM
Regulatory Perspectives on CMC and GMP during Different Phases of Biopharmaceutical Development in US
CMC and GMP are two integral parts of a drug development program. The current GMP law and regulations, however, do not provide any guidance/gu ...continue reading
Wed, 12 Aug 04:45 PM - 05:15 PM
CMC Strategies and Regulatory Considerations for Biobetter Development and Production
While biosimilar development represents the first wave, biobetter development through scientific and technical innovations ensues as the next ...continue reading
Wed, 12 Aug 05:15 PM - 05:45 PM
Validation Strategies for Adopting Single-Use Bioreactors for Commercial Manufacturing of Biologics in China
The Presentation will focus on the regulatory challenges that biologics manufacturers in China are facing for adopting SUBs for commercial man ...continue reading
Wed, 12 Aug 05:45 PM - 05:45 PM
Close of Day One
Thu, 13 Aug 07:45 AM - 08:25 AM
Registration and Coffee with Exhibit and Poster Viewing
Thu, 13 Aug 08:25 AM - 08:30 AM
Chairman's Remarks
Shengjiang Shawn Liu, Ph.D., Head and Principal Scientist, Pathogen Safety, Global Biologics Development, Bayer Healthcare Pharmaceuticals, US ...continue reading
Thu, 13 Aug 08:30 AM - 09:00 AM
Discovering and Developing Biologics for Cancer Therapy
Different modalities of biologics such as monoclonal antibodies, antibody-drug conjugates (ADC), immunotoxins and cytokine-mimics have been de ...continue reading
Thu, 13 Aug 09:00 AM - 09:30 AM
Developing Therapeutic Antibodies in China: Biosimilars and Innovative Biologics
The success of CP GuoJian, a China-based antibody development company, has demonstrated the fast growth of biologics R&D in China over the pas ...continue reading
Thu, 13 Aug 09:30 AM - 10:00 AM
Sherry Guo, Ph.D. Analytical Control System Strategy from Phase I to Post Approval
A risk-based phase-appropriate analytical control system strategy for biologics products will be discussed and illustrated by examples of cont ...continue reading
Thu, 13 Aug 10:00 AM - 10:30 AM
Networking Refreshment Break with Exhibit and Poster Viewing
Thu, 13 Aug 10:00 AM - 10:30 AM
Downstream Development & Viral Safety
Chairperson: Shengjiang Shawn Liu, Ph.D., Head and Principal Scientist, Pathogen Safety, Global Biologics Development, Bayer Healthcare Pharma ...continue reading
Thu, 13 Aug 10:00 AM - 10:30 AM
Biomanufacturing, Facility Readiness and GMP Compliance
Thu, 13 Aug 10:30 AM - 11:00 AM
Protein A: The Untold Story
Protein A is not as simple as it has been considered. Chromatin heteroaggregates accumulate on the resin surface during loading; interfere wit ...continue reading
Thu, 13 Aug 10:30 AM - 11:00 AM
GMP Manufacturing and Quality Control of Antibody-Drug Conjugates (ADCs)
MabPlex has established an ADC manufacturing facility that includes GMP production units for antibody expression, small molecule synthesis, AD ...continue reading
Thu, 13 Aug 11:00 AM - 11:30 AM
Technology Development in Bioreactor Viral Safety
Abstract not available at time of print.Shengjiang Shawn Liu, Ph.D., Head and Principal Scientist, Pathogen Safety, Global Biologics Developme ...continue reading
Thu, 13 Aug 11:00 AM - 11:30 AM
Quality of Technical Operations
The therapeutic values of biologics have been increasingly recognized by the Chinese healthcare community. With the advent of biosimilars, the ...continue reading
Thu, 13 Aug 11:30 AM - 12:00 PM
Viral Clearance Validation with Ready-to-Process Single Use Chromatography Columns
Risk management for viral clearance goes along with the process chain. For removal of adventitious viruses derived from host cell, raw materia ...continue reading
Thu, 13 Aug 11:30 AM - 12:00 PM
Development of a Robust Antibody Drug Conjugation Process - A Case Study
ImmunoGen develops conjugates consisting of proprietary derivatives of the cytotoxic agent maytansine attached to tumor-targeting antibodies. ...continue reading
Thu, 13 Aug 12:00 PM - 12:30 PM
Downstream and Viral Safety Considerations for mAb Therapeutics Production
Development and commercialization of mAb innovative and biosimilar therapeutics is becoming a clear trend in the pharmaceutical industry becau ...continue reading
Thu, 13 Aug 12:00 PM - 12:30 PM
Presentation Title TBA
Speaker TBA, GE Healthcare
Thu, 13 Aug 12:30 PM - 01:30 PM
Networking Luncheon with Exhibit and Poster Viewing
Thu, 13 Aug 01:30 PM - 02:00 PM
Biosimilar Research and Development
Abstract not available at time of print.Li Shi, Ph.D., CEO, Shanghai Zerun Biotechnology Co., Ltd., China
Thu, 13 Aug 02:00 PM - 02:30 PM
Preclinical Development of EGFR Antibody for Colon Cancer
The EGFR monoclonal antibody, vectibix, has been used to treat colon cancer. We have developed its biosimilar antibody BD1001and completed a v ...continue reading
Thu, 13 Aug 02:30 PM - 03:00 PM
MaxCyte - Flow Transfection Systems Shortening the Antibody Development Timeline with Scalable, High-yield Antibody Production via Flow Electroporation
Developing novel biotherapeutics requires the rapid production of gram-level quantities of antibodies. In this presentation, data developed wi ...continue reading
Thu, 13 Aug 03:00 PM - 03:30 PM
Networking Refreshment Break with Poster and Exhibit Viewing
Thu, 13 Aug 03:30 PM - 04:00 PM
Risk-targeted Biosimilar Development and Management
Quality and safety of drugs is a crucial topic for both the public and pharmaceutical companies, especially when biologics and biosimilars bec ...continue reading
Thu, 13 Aug 04:00 PM - 05:00 PM
Partnering Strategies to Advance R&D in China and Asia
Collaboration strategies along the R&D value chain Collaboration models (risk sharing, co-development, options, etc.) Innovation strateg ...continue reading
Thu, 13 Aug 05:00 PM - 05:00 PM
Close of Conference

Exhibitors Profile

BioProcess International Conference & Exhibition China will be participated by potential business partners and collaborators, researchers and developers of biosimilars, biobetters, novel biologics and vaccinations, experienced scientists and engineers and lot more. These professionals will interact with the attendees and scholars and discuss about the various issues and development programs.

31.235344 121.505780

Venue Map & Directions

map of Grand Hyatt Shanghai

Grand Hyatt Shanghai

88 Century Ave, LuJiaZui, Pudong Xinqu, Shanghai Shi 200120
China

Get Directions

Featured Hotels in Shanghai

More Hotels